Revive has joined with BPD. We are now the undisputed leader in health system marketing. Read more here.

Dec 21, 2021

Health brands to watch in 2022

Health brands to watch in 2022 Featuring The No Normal Show of Revive

Driven my big thinkers and bold doers, the health industry is rapidly changing. ​​​​​​​Which health brands caught our attention this year, and which ones will keep it in 2022? The No Normal Team has come up with a list of three to share.


In this episode, Chris, Stephanie, and Chase each reviewed one health brand, discussing why the brand is notable in today’s landscape.

Cityblock: Better care, rooted in communities

  • Chase chose to discuss Cityblock, an emerging primary care organization for low-income communities. 
  • The pandemic highlighted and exacerbated health inequities, spotlighting the growing need to make quality healthcare accessible to low-income populations. In fact, The Commonwealth Fund found that in nearly every state, healthcare is better for white people. 
  • While we see more organizations getting into primary care for the commercially insured, Cityblock is making care more accessible for Medicare-insured populations.
  • Cityblock is unique because they meet people where they’re at – existing schools, churches, and community centers.
  • Cityblock hires a lot of its medical care team members from the communities they serve. This helps the primary care innovator build trust and understanding with the communities it serves.
  • Cityblock recently announced their Series D round of funding, bringing total funding to $900 million. 

Hims & Hers: A modern approach to health and wellness

  • Hims & Hers is a company that encompasses prescription medicine, primary care, supplements, and CPG products. 
  • The company is built to provide better care to consumers with stigmatized conditions, such as those related to sexual health, mental health, and beauty.
  • The company uniquely brings together prescription, beauty, and home health using a telemedicine platform and retail distribution networks. 
  • The company’s valuation at IPO was about $1.6 billion, which is on par with what we’ve seen with OneMedical, showing gradual revenue growth over time. 
  • A lot of companies have tried to disrupt the pharmacy business, but many have failed because of cemented power dynamics and complex inner workings. 
  • Hims & Hers is breaking into this arena by making medicine less intimidating through beautiful design and branding. The No Normal team posits that consumers may find it less scary to receive a prescription in a beautiful bottle than a regular sick package. 

Apple: Think different

  • Chris chose Apple to focus on as a health brand because most people don’t consider apple a health brand, despite Tim Cook’s bold belief that Apple’s legacy will be in health.
  • From fall detection features to EMR integrations, Apple’s progression into healthcare has been steadily marked by high-tech devices, including wearables like Apple Watch and AirPods. 
  • Walking steadiness is a particularly notable feature because it is a new clinical metric that can be credited to a “non-healthcare” brand. We use quotes here for a reason. Apple, whether you believe it or not, is one of the fastest-growing health brands out there. 
  • Apple may have faltered a time or two as it entered the healthcare arena, but these stumbles are merely learning opportunities that the giant will use to inform future efforts. 
  • Apple was the first company to reach $1 trillion after 42 years of business. It took only two more years to be valued at $2 trillion. They are known for design and innovation and have enough capital to invest in healthcare. If you connect the dots, the reality is clear: Apple is ready to take on health care … whether systems are ready or not.